focus -WSS

focus

author：focus 2025-09-29 01:06:46 - browse：21

Micrograph of ulcerative colitis -- biotech coverage from STAT — Micrograph of chronic active ulcerative colitis in a biopsy specimen. Wikimedia Commons

Checkpoint inhibitors, drugs that unleash the immune system, have turned into blockbuster therapies that have transformed outcomes for some patients with deadly cancers. AltruBio, a Bay Area biotech, is betting it can help patients suffering from autoimmune and inflammatory diseases by taking the opposite tack: pumping the brakes on runaway immune responses.

The company on Tuesday announced that it has raised $225 million in a Series B venture round led by BVP Partners, with the biotech’s backers also including RA Capital Management, Cormorant Asset Management, and Soleus Capital. AltruBio plans to put that money toward advancing a drug that is already being tested in a mid-stage trial for ulcerative colitis, an increasingly competitive market in which a number of pharma companies have launched drugs.

It’s the latest example of intense investor interest in immunology-focused companies. Firms such as Paragon Therapeutics and Prometheus Laboratories have recently been at the center of financing mega-rounds, and Blackstone Life Sciences recently committed up to $300 million to launch Uniquity Bio, a company developing treatments for asthma and chronic obstructive pulmonary disease.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Dogs on Prozac: What pet anti

WSS

5 wounded, 2 critically, in Michigan shopping center shooting

Melinda French Gates resigns from Gates Foundation

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Why does health care cost so much? A reading guide

Snowpack in the West is melting rapidly. Where will all that extra water go?

leisure time

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Anesthesiologist group: stop taking Ozempic before surgery

Doctors increasingly discourage vaping amid mounting health concerns

The cancer drug shortage isn’t new — and neither are the solutions

Cholera vaccine supply gets boost as demand surges globally

Medicare proposal to cover medical devices draws a mixed reaction

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Trump demands the U.S. pay no more for drugs than other countries … again

Why does health care cost so much? A reading guide

Guidelines to prevent youth baseball injuries need more muscle

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Wikipedia

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Cancer researcher Catriona Jamieson is sending tumors into space

Why rehabilitation engineers need to center patients in their research

House GOP plan to stem drug shortages differs from Democrats’

Wikipedia

hotspot

focus

entertainment